Endocytosis of the dermatan sulfate proteoglycan decorin utilizes multiple pathways and is modulated by epidermal growth factor receptor signaling

Biochimie

Volumn 89, Issue 5, 2007, Pages 637-657

  Feugaing, David Denis Sofeu ^a   Tammi, Raija ^b   Echtermeyer, Frank G ^a   Stenmark, Harald ^c   Kresse, Hans ^a   Smollich, Martin ^a   Schönherr, Elke ^a   Kiesel, Ludwig ^a   Götte, Martin ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Dermatan sulfate proteoglycan; Extracellular matrix; Hyaluronan; SLRP

Indexed keywords

CHLORPROMAZINE; CLATHRIN; DECORIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FILIPIN; HERMES ANTIGEN; HYALURONIC ACID; SULFATE; WORTMANNIN;

ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOCYTOSIS; ENDOSOME; HUMAN; HUMAN TISSUE; LYSOSOME; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

CHLORPROMAZINE; CHOLESTEROL; CLATHRIN; DERMATAN SULFATE; ENDOCYTOSIS; EXTRACELLULAR MATRIX PROTEINS; FIBROBLASTS; FILIPIN; HUMANS; PROTEIN TRANSPORT; PROTEOCHONDROITIN SULFATES; PROTEOGLYCANS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SKIN;

EID: 34247579085     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2006.12.012     Document Type: Article

References (94)

1. Kresse H., and Schönherr E. Proteoglycans of the extracellular matrix and growth control. J. Cell. Physiol. 189 (2001) 266-274
2. Kinsella M.G., Bressler S.L., and Wight T.N. The regulated synthesis of versican, decorin, and biglycan: extracellular matrix proteoglycans that influence cellular phenotype. Crit. Rev. Eukaryot. Gene Expr. 14 (2004) 203-234
3. Scott P.G., McEwan P.A., Dodd C.M., Bergmann E.M., Bishop P.N., and Bella J. Crystal structure of the dimeric protein core of decorin, the archetypal small leucine-rich repeat proteoglycan. Proc. Natl. Acad. Sci. USA. 101 (2004) 15633-15638
4. Tufvesson E., and Westergren-Thorsson G. Tumour necrosis factor-alpha interacts with biglycan and decorin. FEBS Lett. 530 (2002) 124-128
5. 2+-dependent interaction. J. Biol. Chem. 278 (2003) 13655-13662
6. Elefteriou F., Exposito J.Y., Garrone R., and Lethias C. Binding of tenascin-X to decorin. FEBS Lett. 495 (2001) 44-47
7. Font B., Aubert-Foucher E., Goldschmidt D., Eichenberger D., and van der Rest M. Binding of collagen XIV with the dermatan sulfate side chain of decorin. J. Biol. Chem. 268 (1993) 25015-25018
8. Zamfir A., Seidler D.G., Kresse H., and Peter-Katalinic J. Structural investigation of chondroitin/dermatan sulfate oligosaccharides from human skin fibroblast decorin. Glycobiology 13 (2003) 733-742
9. Taylor K.R., Rudisill J.A., and Gallo R.L. Structural and sequence motifs in dermatan sulfate for promoting fibroblast growth factor-2 (FGF-2) and FGF-7 activity. J. Biol. Chem. 280 (2005) 5300-5306
10. Danielson K.G., Baribault H., Holmes D.F., Graham H., Kadler K.E., and Iozzo R.V. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J. Cell Biol. 136 (1997) 729-743
11. Neame P.J., Kay C.J., McQuillan D.J., Beales M.P., and Hassell J.R. Independent modulation of collagen fibrillogenesis by decorin and lumican. Cell. Mol. Life Sci. 57 (2000) 859-863
12. Pulkkinen L., Kainulainen K., Krusius T., Makinen P., Schollin J., Gustavsson K.H., and Peltonen L. Deficient expression of the gene coding for decorin in a lethal form of Marfan syndrome. J. Biol. Chem. 265 (1990) 17780-17785
13. Götte M., and Kresse H. Defective glycosaminoglycan substitution of decorin in a patient with progeroid syndrome is a direct consequence of two point mutations in the galactosyltransferase I (beta4GalT-7) gene. Biochem. Genet. 43 (2005) 65-77
14. Seidler D.G., Faiyaz-Ul-Haque M., Hansen U., Yip G.W., Zaidi S.H., Teebi A.S., Kiesel L., and Götte M. Defective glycosylation of decorin and biglycan, altered collagen structure, and abnormal phenotype of the skin fibroblasts of an Ehlers-Danlos syndrome patient carrying the novel Arg270Cys substitution in galactosyltransferase I (beta4GalT-7). J. Mol. Med. 84 (2006) 583-594
15. Maquart F.X., Simeon A., Pasco S., and Monboisse J.C. Regulation of cell activity by the extracellular matrix: the concept of matrikines. J. Soc. Biol. 193 (1999) 423-428
16. Maquart F.X., Pasco S., Ramont L., Hornebeck W., and Monboisse J.-C. An introduction to matrikines: extracellular matrix-derived peptides which regulate cell activity. Implication in tumor invasion. Crit. Rev. Oncol. Hematol. 49 (2004) 199-202
17. Csordas G., Santra M., Reed C.C., Eichstetter I., McQuillan D.J., Gross D., Nugenti M.A., Hajnóczky G., and Iozzo R.V. Sustained down-regulation of the epidermal growth factor receptor by decorin. A mechanism for controlling tumor growth in vivo. J. Biol. Chem. 275 (2000) 32879-32887
18. Zhu J.X., Goldoni S., Bix G., Owens R.T., McQuillan D.J., Reed C.C., and Iozzo R.V. Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis. J. Biol. Chem. 280 (2005) 32468-32479
19. Schönherr E., Sunderkötter C., Iozzo R.V., and Schaefer L. Decorin, a novel player in the insulin-like growth factor system. J. Biol. Chem. 280 (2005) 15767-15772
20. Schönherr E., Levkau B., Schaefer L., Kresse H., and Walsh K. Decorin-mediated signal transduction in endothelial cells. Involvement of Akt/protein kinase B in up-regulation of p21(WAF1/CIP1) but not p27(KIP1). J. Biol. Chem. 276 (2001) 40687-40692
21. Bi Y., Stuelten C.H., Kilts T., Wadhwa S., Iozzo R.V., Robey P.G., Chen X.D., and Young M.F. Extracellular matrix proteoglycans control the fate of bone marrow stromal cells. J. Biol. Chem. 280 (2005) 30481-30489
22. Tufvesson E., and Westergren-Thorsson G. Biglycan and decorin induce morphological and cytoskeletal changes involving signalling by the small GTPases RhoA and Rac1 resulting in lung fibroblast migration. J. Cell Sci. 116 (2003) 4857-4864
23. Moscatello D.K., Santra M., Mann D.M., McQuillan D.J., Wong A.J., and Iozzo R.V. Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. J. Clin. Invest. 101 (1998) 406-412
24. Schaefer L., Macakova K., Raslik I., Micegova M., Gröne H.-J., Schönherr E., Robenek H., Echtermeyer F.G., Grässel S., Bruckner P., Schaefer R.M., Iozzo R.V., and Kresse H. Absence of decorin adversely influences tubulointerstitial fibrosis of the obstructed kidney by enhanced apoptosis and increased inflammatory reaction. Am. J. Pathol. 160 (2002) 1181-1191
25. Kolb M., Margetts P.J., Sime P.J., and Gauldie J. Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 280 (2001) L1327-L1334
26. Yip G.W., Smollich M., and Götte M. Therapeutic value of glycosaminoglycans in cancer. Mol. Cancer Ther. 25 (2006) 2139-2148
27. Troup S., Njue C., Kliewer E.V., Parisien M., Roskelley C., Chakravarti S., Roughley P.J., Murphy L.C., and Watson P.H. Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin. Cancer Res. 9 (2003) 207-214
28. Smid-Koopman E., Blok L.J., Chadha-Ajwani S., Helmerhorst T.J., Brinkmann A.O., and Huikeshoven F.J. Gene expression profiles of human endometrial cancer samples using a cDNA-expression array technique: assessment of an analysis method. Br. J. Cancer 83 (2000) 246-251
29. Nash M.A., Deavers M.T., and Freedman R.S. The expression of decorin in human ovarian tumors. Clin. Cancer Res. 8 (2002) 1754-1760
30. Tralhao J.G., Schaefer L., Micegova M., Evaristo C., Schönherr E., Kayal S., Veiga-Fernandes H., Danel C., Iozzo R.V., Kresse H., and Lemarchand P. In vivo selective and distant killing of cancer cells using adenovirus-mediated decorin gene transfer. FASEB J 17 (2003) 464-466
31. Reed C.C., Gauldie J., and Iozzo R.V. Suppression of tumorigenicity by adenovirus-mediated gene transfer of decorin. Oncogene 21 (2002) 3688-3695
32. Hausser H., Hoppe W., Rauch U., and Kresse H. Endocytosis of small dermatan sulphate proteoglycan. Identification of binding sites. Biochem. J. 263 (1989) 137-142
33. Götte M., Kresse H., and Hausser H. Endocytosis of decorin by bovine aortic endothelial cells. Eur. J. Cell Biol. 66 (1995) 226-233
34. Schaefer L., Hausser H., Altenburger M., Ugorcakova J., August C., Fisher L.W., Schaefer R.M., and Kresse H. Decorin, biglycan and their endocytosis receptor in rat renal cortex. Kidney Int. 54 (1998) 1529-1541
35. Sofeu Feugaing D.D., Kresse H., Greb R.R., and Götte M. A novel 110-kDa receptor protein is involved in endocytic uptake of decorin by human skin fibroblasts. Sci. World J. 6 (2006) 35-52
36. Hausser H., Wedekind P., Sperber T., Peters R., Hasilik A., and Kresse H. Isolation and cellular localization of the decorin endocytosis receptor. Eur. J. Cell Biol. 71 (1996) 325-331
37. Iozzo R.V., Moscatello D.K., McQuillan D.J., and Eichstetter I. Decorin is a biological ligand for the epidermal growth factor receptor. J. Biol. Chem. 274 (1999) 4489-4492
38. Santiago-Garcia J., Kodama T., and Pitas R.E. The class A scavenger receptor binds to proteoglycans and mediates adhesion of macrophages to the extracellular matrix. J. Biol. Chem. 278 (2003) 6942-6946
39. Hoppe W., Rauch U., and Kresse H. Degradation of endocytosed dermatan sulfate proteoglycan in human skin fibroblasts. J. Biol. Chem. 263 (1988) 5926-5932
40. Hausser H., and Kresse H. Binding of heparin and of the small proteoglycan decorin to the same endocytosis receptor protein leads to different metabolic consequences. J. Cell Biol. 114 (1991) 45-52
41. Cantz M., Kresse H., Barton R.W., and Neufeld E.F. Corrective factors for inborn errors of mucopolysaccharide metabolism. Methods Enzymol. 28 (1972) 884-897
42. Hager B., Bickenbach J.R., and Fleckman P. Long-term culture of murine epidermal keratinocytes. J. Invest. Dermatol. 112 (1991) 971-976
43. Raiborg C., Bache K.G., Mehlum A., Stang E., and Stenmark H. Hrs recruits clathrin to early endosomes. EMBO J. 20 (2001) 5008-5021
44. Osherov N., and Levitzki A. Epidermal growth-factor-dependent activation of the Src-family kinases. Eur. J. Biochem. 225 (1994) 1047-1053
45. Parrizas M., Gazit A., Levitzki A., Wertheimer E., and LeRoith D. Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins. Endocrinology 138 (1997) 1427-1433
46. KIP1 independent of MAPK activity. J. Biol. Chem. 275 (2000) 6987-6995
47. Schmidt M.H.H., Furnari F.B., Cavenee W.K., and Bögler O. Epidermal growth factor receptor signaling intensity determines intracellular protein interactions, ubiquitination, and internalization. Proc. Natl. Acad. Sci. USA. 100 (2003) 6505-6510
48. Heuser J.E., and Anderson R.G. Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation. J. Cell Biol. 108 (1989) 389-400
49. Wang L.H., Rothberg K.G., and Anderson R.G. Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J. Cell Biol. 123 (1993) 1107-1117
50. Götte M., Sofeu Feugaing D.D., and Kresse H. Biglycan is internalized via a chlorpromazine-sensitive route. Cell. Mol. Biol. Lett. 9 (2004) 475-481
51. Schnitzer J.E., Oh P., Pinney E., and Allard J. Filipin-sensitive caveolae-mediated transport in Endothelium: reduced transcytosis, scavenger -endocytosis, and capillary permeability of select macromolecules. J. Cell Biol. 127 (1994) 1217-1232
52. Parton R.G., and Richards A.A. Lipid rafts and caveolae as portals for endocytosis: new insights and common mechanisms. Traffic 4 (2003) 724-738
53. Tammi R., Rilla K., Pienima K., Juha-Pekka I., MacCallum D.K., Hogg M., Luukkonen M., Hascall V.C., and Tammi M. Hyaluronan enters keratinocytes by a novel endocytic route for catabolism. J. Biol. Chem. 276 (2001) 35111-35122
54. Liu N.Q., Lossinsky A.S., Popik W., Li X., Gujuluva C., Kriederman B., Roberts J., Pushkarsky T., Bukrinsky M., Witte M., Weinand M., and Fiala M. Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway. J. Virol. 76 (2002) 6689-6700
55. Dharmawardhane S., Schurmann A., Sells M.A., Chernoff J., Schmid S.L., and Bokoch G.M. Regulation of macropinocytosis by p21-activated kinase-1. Mol. Biol. Cell. 11 (2000) 3341-3352
56. Vanhaesebroeck B., and Waterfield M.D. Signalling by distinct classes of phosphoinositide 3-kinases. Exp. Cell Res. 253 (1999) 239-254
57. Spiro D.J., Boll W., Kirchhausen T., and Wessling-Resnick M. Wortmannin alters the transferrin receptor endocytic pathway in vivo and in vitro. Mol. Biol. Cell 7 (1996) 355-367
58. Mousavi S.A., Brech A., Berg T., and Kjeken R. Phosphoinositide 3-kinase regulates maturation of lysosomes in rat hepatocytes. Biochem. J. 372 (2003) 861-869
59. Simonsen A., Lippé R., Christoforidis S., Gaullier J.M., Brech A., Callaghan J., Toh B.H., Murphy C., Zerial M., and Stenmark H. EEA1 links PI (3) K function to Rab5 regulation of endosome fusion. Nature 394 (1998) 494-498
60. Jones A.T., Mills I.G., Scheidig A.J., Alexandrov K., and Clague M.J. Inhibition of endosome fusion by wortmannin persists in the presence of activated rab5. Mol. Biol. Cell 9 (1998) 323-332
61. Shpetner H., Joly M., Hartley D., and Corvera S. Potential sites of PI-3 kinase function in the endocytic pathway revealed by the PI-3 kinase inhibitor, wortmannin. J. Cell Biol. 132 (1996) 595-605
62. Götte M., and von Mollard G.F. A new beat for the SNARE drum. Trends Cell Biol. 8 (1998) 215-218
63. Chin L., Raynor M.C., Wei X., Chen H., and Li L. Hrs interacts with sorting nexin 1 and regulates degradation of epidermal growth factor receptor. J. Biol. Chem. 276 (2001) 7069-7078
64. Futter C.E., Collinson L.M., Backer J.M., and Hopkins C.R. Human VPS34 is required for internal vesicle formation within multivesicular endosomes. J. Cell Biol. 155 (2001) 1251-1263
65. Li Y., Chin L.-S., Levey A.I., and Li L. Huntingtin-associated protein 1 interacts with hepatocyte growth factor-regulated tyrosine kinase substrate and functions in endosomal trafficking. J. Biol. Chem. 277 (2002) 28212-28221
66. Rubino M., Miaczynska M., Lippe R., and Zerial M. Selective membrane recruitment of EEA1 suggests a role in directional transport of clathrin-coated vesicles to early endosomes. J. Biol. Chem. 275 (2000) 3745-3748
67. Bache K.G., Raiborg C., Mehlum A., Madshus I.H., and Stenmark H. Phosphorylation of Hrs downstream of the epidermal growth factor receptor. Eur. J. Biochem. 269 (2002) 3881-3887
68. Bache K.G., Raiborg C., Mehlum A., and Stenmark H. STAM and Hrs are subunits of a multivalent ubiquitin-binding complex on early endosomes. J. Biol. Chem. 278 (2003) 12513-12521
69. Kandror K.V., and Pilch P.F. Multiple endosomal recycling pathways in rat adipose cells. Biochem. J. 331 (1998) 829-835
70. Sheff D.R., Daro E.A., Hull M., and Mellman I. The receptor recycling pathway contains two distinct populations of early endosomes with different sorting functions. J. Cell Biol. 145 (1999) 123-139
71. Anderson R. The caveolae membrane system. Annu. Rev. Biochem. 67 (1998) 199-225
72. Mineo C., James G.L., Smart E.J., and Anderson R.G.W. Localization of epidermal growth factor-stimulated Ras/Raf-1 interaction to caveolae membrane. J. Biol. Chem. 271 (1996) 11930-11935
73. Mineo C., Gill G.N., and Anderson R.G.W. Regulated migration of epidermal growth factor receptor from caveolae. J. Biol. Chem. 274 (1999) 30636-30643
74. Nabi I.R., and Le P.U. Caveolae/raft-dependent endocytosis. J. Cell Biol. 161 (2003) 673-677
75. Okamoto T., Schlegel A., Scherer P.E., and Lisanti M.P. Caveolins, a family of scaffolding proteins for organizing "pre-assembled signaling complexes" at the plasma membrane. J. Biol. Chem. 273 (1998) 5419-5422
76. Jiang H., Peterson R.S., Wang W., Bartnik E., Knudson C.B., and Knudson W. A requirement for the CD44 cytoplasmic domain for hyaluronan binding, pericellular matrix assembly, and receptor-mediated endocytosis in COS-7 cells. J. Biol. Chem. 277 (2002) 10531-10538
77. Weigel J.A., and Weigel P.H. Characterization of the recombinant Rat 175-kDa hyaluronan receptor for endocytosis (HARE). J. Biol. Chem. 278 (2003) 42802-42811
78. Laurent T.C., and Fraser R.E. Hyaluronan. FASEB J. 6 (1992) 2397-2404
79. Burke P., Schooler K., and Wiley H.S. Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking. Mol. Biol. Cell 12 (2001) 1897-1910
80. Jiang X., and Sorkin A. Epidermal growth factor receptor internalization through clathrin-coated pits requires Cbl RING finger and proline-rich domains but not receptor polyubiquitylation. Traffic 4 (2003) 529-543
81. Barbieri M.A., Roberts R.L., Gumusboga A., Highold H., Alvarez-Dominguez C., Wells A., and Stahl P.D. Epidermal growth factor and membrane trafficking: EGF receptor activation of endocytosis requires Rab5a. J. Cell Biol. 151 (2000) 539-550
82. Aguilar R.C., and Wendland B. Endocytosis of membrane receptors: two pathways are better than one. Proc. Natl. Acad. Sci. USA. 102 (2005) 2679-2680
83. Simons K., and Toomre D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell. Biol. 1 (2000) 31-39
84. Quest A.F.G., Leyton L., and Párraga M. Caveolins, caveolae, and lipid rafts in cellular transport, signalling, and disease. Biochem. Cell Biol. 82 (2004) 129-144
85. Lai E.C. Lipid rafts make for slippery platforms. J. Cell Biol. 162 (2003) 365-370
86. Signoret N., Hewlett L., Wavre S., Pelchen-Mattews A., Oppermann M., and Marsh M. Agonist-induced endocytosis of CC chemokine receptor 5 is clathrin dependent. Mol. Biol. Cell 16 (2005) 902-917
87. Chen X., and Wang Z. Regulation of the intracellular trafficking of the EGF receptor by Rab5 in the absence of phosphatidylinositol 3-kinase activity. EMBO Rep 2 (2001) 68-74
88. Martys J.L., Wjasow C., Gangi D.M., Lielian M.C., McGraw T.E., and Baker J.M. Wortmannin-sensitive trafficking pathways in Chinese hamster ovary cells. Differential effects on endocytosis and lysosomal sorting. J. Biol. Chem. 271 (1996) 10953-10962
89. Houle S., and Marceau F. Wortmannin alters the intracellular trafficking of the bradykinin B2 receptor: role of phosphoinositide 3-kinase and Rab5. Biochem. J. 375 (2003) 151-158
90. Schaefer L., Babelova A., Kiss E., Hausser H.J., Baliova M., Krzyzankova M., Marsche G., Young M.F., Mihalik D., Götte M., Malle E., Schaefer R.M., and Gröne H.J. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J. Clin. Invest. 115 (2005) 2223-2233
91. Moreno M., Munoz R., Aroca F., Labarca M., Brandan E., and Larrain J. Biglycan is a new extracellular component of the Chordin-BMP4 signaling pathway. EMBO J. 24 (2005) 1397-1405
92. Chen X.D., Fisher L.W., Robey P.G., and Young M.F. The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation. FASEB J. 18 (2004) 948-958
93. Hayashi Y., Liu C.Y., Jester J.J., Hayashi M., Wang I.J., Funderburgh J.L., Saika S., Roughley P.J., Kao C.W., and Kao W.W. Excess biglycan causes eyelid malformation by perturbing muscle development and TGF-alpha signaling. Dev. Biol. 277 (2005) 222-234
94. Groth S., Schulze M., Kalthoff H., Fandrich F., and Ungefroren H. Adhesion and Rac1-dependent regulation of biglycan gene expression by transforming growth factor-beta. Evidence for oxidative signaling through NADPH oxidase. J. Biol. Chem. 280 (2005) 33190-33199